Document
IPR2017-01429, No. 1044-45 Exhibit - EX1044 Declaration of Jeff Karr (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01429, No. 1044-45 Exhibit - EX1044 Declaration of Jeff Karr (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01429, No. 1015-16 Exhibit - EX1015 Kaken Abstracts (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01429, No. 1015-16 Exhibit - EX1015 Kaken Abstracts (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-01429, No. 1043-44 Exhibit - EX1043 Jublia package insert (P.T.A.B. May. 12, 2017)
Cite Document
IPR2017-01429, No. 1043-44 Exhibit - EX1043 Jublia package insert (P.T.A.B. May. 12, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1504 Exhibit - Meeting Minutes for IND 77732, Division of Dermatology and Dental Products Office of Drug Evaluation III (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1504 Exhibit - Meeting Minutes for IND 77732, Division of Dermatology and Dental Products Office of Drug Evaluation III (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1513 Exhibit - Exhibit 1513a Tadashi Arika et al, Nishi Nihon Journal of Dermatology, 52 3 545 549 1990 (P.T.A.B. Jan. 5, 2018)
Cite Document
IPR2017-00190, No. 1513 Exhibit - Exhibit 1513a Tadashi Arika et al, Nishi Nihon Journal of Dermatology, 52 3 545 549 1990 (P.T.A.B. Jan. 5, 2018)
+ More Snippets
Document
IPR2017-00190, No. 2118 Exhibit - Kaken Exhibit 2118 (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-00190, No. 2118 Exhibit - Kaken Exhibit 2118 (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1001 Exhibit - US Pat No 7,214,506 (P.T.A.B. Nov. 2, 2016)
Cite Document
IPR2017-00190, No. 1001 Exhibit - US Pat No 7,214,506 (P.T.A.B. Nov. 2, 2016)
+ More Snippets
Document
IPR2017-00190, No. 1671 Exhibit - Declaration of John C Staines, Jr in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Jan. ...
Cite Document
IPR2017-00190, No. 1671 Exhibit - Declaration of John C Staines, Jr in Support of Petitioners¿¿¿ Response to Patent Owner¿¿¿s Objections to Evidence Served November 22, 2017 (P.T.A.B. Jan. 5, 2018)
+ More Snippets
Document
IPR2017-00190, No. 1510 Exhibit - Declaration of Jeffrey M Weinberg, MD in Support of Petitioner¿¿¿s Reply to Patent Owner¿¿¿s Response (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1510 Exhibit - Declaration of Jeffrey M Weinberg, MD in Support of Petitioner¿¿¿s Reply to Patent Owner¿¿¿s Response (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1503 Exhibit - Guidelines for treatment of onychomycosis (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1503 Exhibit - Guidelines for treatment of onychomycosis (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1500 Exhibit - Update on the management of onychomycosis highlights of the third annual international summit on cutaneous antifungal therapy (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1500 Exhibit - Update on the management of onychomycosis highlights of the third annual international summit on cutaneous antifungal therapy (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1513 Exhibit - Antibacterial activity of topical antifungal agent in the infected sites study skin permeability and absorption to horny materials (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1513 Exhibit - Antibacterial activity of topical antifungal agent in the infected sites study skin permeability and absorption to horny materials (P.T.A.B. Nov. 1, 2017)
+ More Snippets
Document
IPR2017-00190, No. 1544 Exhibit - Exhibit 1544a ¿¿¿The King¿¿¿s Gambit Valeant¿¿¿s Big Secret,¿¿¿ R Boyd, Southern Investigative Reporting Foundation, October 19, 2015 (P.T.A.B. Jan. 5, 2018...
Cite Document
IPR2017-00190, No. 1544 Exhibit - Exhibit 1544a ¿¿¿The King¿¿¿s Gambit Valeant¿¿¿s Big Secret,¿¿¿ R Boyd, Southern Investigative Reporting Foundation, October 19, 2015 (P.T.A.B. Jan. 5, 2018)
+ More Snippets
Document
IPR2017-00190, No. 1535 Exhibit - Exhibit 1535a Pharmacy Benefit Management Are Reporting Requirements Pro or Anticompetitive¿¿¿ PM Danzon, International Journal of the Economics of B...
Cite Document
IPR2017-00190, No. 1535 Exhibit - Exhibit 1535a Pharmacy Benefit Management Are Reporting Requirements Pro or Anticompetitive¿¿¿ PM Danzon, International Journal of the Economics of Business, 22224
+ More Snippets
Document
IPR2017-00190, No. 1505 Exhibit - US Pat No 5,962,476 to Naito et al (P.T.A.B. Nov. 1, 2017)
Cite Document
IPR2017-00190, No. 1505 Exhibit - US Pat No 5,962,476 to Naito et al (P.T.A.B. Nov. 1, 2017)
+ More Snippets